Sanofi Posts Strong Earnings as Dupixent Demand Keeps Growing

» Sanofi Posts Strong Earnings as Dupixent Demand Keeps Growing

By:
On:
In: Business
With: 0 Comments




Sanofi SA reported better-than-expected profit in the first quarter, boosted by strong demand for its blockbuster skin and asthma drug Dupixent.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *